Risk adjusted net present value: What is the current valuation of Pfizer’s Idrebormilast?
Idrebormilast is a small molecule commercialized by Pfizer, with a leading Phase II program in Rosacea.
Idrebormilast is a small molecule commercialized by Pfizer, with a leading Phase II program in Rosacea.
What's Your Reaction?
